Flu season visitor restriction – age 16 or older (Restricción de visitantes durante la Temporada de Influenza (Flu) – Mayores de 16 años.)

Flu Season Visitor Restriction

Visitors temporarily restricted to age 16 or older

As a safety first organization, Christiana Care is implementing a temporary visitation age restriction starting Friday, Jan. 18. This temporary restriction protects patients, their loved ones and health care workers during this time of extremely high number of influenza cases and other respiratory illnesses circulating in our community.

The new restrictions limit visitors to patients in Christiana and Wilmington hospitals to persons age 16 or older. Children and teens younger than 16 years are most likely to get the flu and remain contagious longer than adults. This restriction does not apply to outpatient and ambulatory services. We began restricting visitors under the age of 16 years in our Neonatal Intensive Care Unit (NICU) and Women’s and Children’s areas on Jan. 18.

Thank you for your understanding and cooperation.

For more information about the Flu visit our Health Library.


Restricción de visitantes durante la Temporada de Influenza (Flu)

Temporalmente solo se permiten los visitantes mayores de 16 años.

Como una organización que promueve la seguridad ante todo, Christiana Care está implementando una restricción temporal en la edad de visitantes a partir del viernes 18 de enero. Esta restricción temporal protege a los pacientes, a sus seres queridos y al personal de cuidados de salud durante esta época con un número extremadamente alto de casos de influenza y de otras enfermedades respiratorias que circulan en nuestra comunidad.

Las nuevas restricciones, en los hospitales Christiana y Wilmington, sólo permiten visitas a pacientes de personas mayores de 16 años. Los niños y adolescentes menores de 16 años son más propensos a contraer el flu y son contagiosos por más tiempo que los adultos. Esta restricción no aplica a las áreas de servicios ambulatorios. Comenzamos la restricción de visitas a menores de 16 años en nuestra Unidad de Cuidados Intensivos Neonatales (NICU) y en las áreas para Mujeres y Niños desde el 18 de enero.

Gracias por su comprensión y cooperación.

Para más información sobre la gripe, visite nuestra Biblioteca de Salud.

Cancer Research at the
Helen F. Graham Cancer Center
& Research Institute

Cancer Clinical Trials

Christiana Care’s Cancer Research Program is part of a select group of 46 research centers (34 community sites and 12 minority/under-served sites) in the United States and Puerto Rico that are funded by the National Cancer Institute to participate in the NCI Community Oncology Research Program (NCORP). Thousands of patients throughout the Delaware region have benefited from studies conducted under the auspices of the NCORP, as well as from a variety of other federally funded and industry-supported cancer treatment, prevention and control trials. Many of these trials take place on a national or international level at approved research centers around the country and throughout the world.

Christiana Care also takes part in NCI-funded Cancer Care Delivery Research (CCDR) which is focused on patient, provider and organizational-level  influences on cancer outcomes.

Clinical trials test new drugs and combinations of treatments, as well as new techniques using surgery, radiation therapy, gene therapy, immunotherapy and biologics. Research studies encompass a wide range of cancer-related disciplines including hematology/oncology, radiation oncology and gynecologic oncology.

Clinical trials offered by Christiana Care attract participants from Delaware, New Jersey, Maryland and Pennsylvania. Delaware research affiliates that include Beebe Healthcare, Tunnell Cancer Center and Nanticoke Health Services Cancer Care Center participate in NCI research. Our annual accrual rate—which measures the percentage of patients enrolled in clinical trials—among newly diagnosed cancer patients is among the highest in the nation. At any given time, we have at least 700 patients enrolled in as many as 100 different clinical trials.

All studies are first approved by the National Cancer Institute Central Institutional Review Board and/or Christiana Care’s Institutional Review Board, a special committee that reviews and oversees all research projects to ensure that participants’ rights and welfare are protected.

Cancer Research Program
Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road, Newark, DE 19713 directions
For more information, call 302-623-4450 or e-mail us.